CRL Launches Apollo Orchestrate with Autolomous for Biologics Quality Control
Charles River Laboratories International (NYSE: CRL) has partnered with digital solution provider Autolomous to launch Apollo Orchestrate, a new digital laboratory execution system integrated into its flagship Apollo platform. The tool is designed to digitize and automate workflows in biologics quality control by leveraging Autolomous's autoloMATE® Laboratory Execution System. This innovation aims to enhance efficiency and accuracy across lab operations for Charles River’s clients, particularly those involved in the development of complex biological therapies. By integrating advanced digital capabilities into its existing platform, CRL is positioning itself at the forefront of laboratory automation solutions within the life sciences industry.
Tickers: $CRL
Topics: digital transformation laboratory automation product launch